Mode
Text Size
Log in / Sign up

Heart failure doubles mortality risk in ischemic stroke patients undergoing mechanical thrombectomyHeart Failure Linked to Higher Mortality After Ischemic Stroke

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that heart failure patients undergoing mechanical thrombectomy have higher mortality and worse functional outcomes.

This meta-analysis evaluated outcomes in 3587 patients with ischemic stroke undergoing mechanical thrombectomy, specifically comparing those with and without heart failure (HF). The analysis indicates that patients with HF experienced a significantly higher mortality rate (RR 2.01; 95% CI: 1.33-3.03; p < 0.01) and a lower risk of favorable neurologic outcomes (RR 0.76; 95% CI: 0.67-0.86; p < 0.01) at 90 days.

Subgroup analysis of HF patients with reduced LVEF showed higher mortality (RR 1.91; 95% CI: 1.05-3.49; p = 0.03) and worse functional outcomes (RR 0.83; 95% CI: 0.72-0.95; p < 0.01) compared to patients without HF. Notably, the study found no significant differences in recanalization success (RR 1.02; 95% CI: 0.98-1.07; p = 0.28) or symptomatic intracranial hemorrhage (RR 1.57; 95% CI: 0.98-2.51; p = 0.06) between the groups.

Clinically, these results suggest that while the immediate technical success of mechanical thrombectomy (recanalization and sICH rates) may be comparable, the 90-day clinical prognosis is significantly worse for patients with comorbid heart failure. The association is based on a meta-analysis of observational and clinical data.

How this fits prior evidence

This meta-analysis addresses a gap in understanding how heart failure impacts outcomes in acute stroke management. While previous coverage noted that heart failure evidence in Somalia is fragmented and insufficient for national burden estimates, this study provides specific data on the 90-day mortality and functional outcomes for heart failure patients undergoing mechanical thrombectomy. It confirms that heart failure is associated with higher mortality (RR 2.01) and lower favorable neurologic outcomes (RR 0.76) in this specific stroke population.

A large review of data involving over 3,500 patients found that those with heart failure who underwent mechanical thrombectomy for an ischemic stroke had different outcomes than those without heart failure. Specifically, patients with heart failure showed a significantly higher risk of death and a lower likelihood of achieving a favorable neurological outcome at the 90-day mark.

Interestingly, the study found no significant difference between the two groups regarding the success of recanalization or the risk of symptomatic intracranial hemorrhage. This means that while the immediate technical success of the procedure was similar, the long-term recovery and survival rates were lower for those with underlying heart conditions.

These findings suggest that heart failure is a significant factor in how a patient recovers from a stroke. Because these results come from a meta-analysis of existing data, they show a link rather than a direct cause. Patients with both conditions should discuss these specific risks with their medical team to manage their long-term care.

What this means for you:
Patients with heart failure may face higher mortality and lower recovery rates after a stroke.

Common questions

How does heart failure affect stroke recovery?

Patients with heart failure who undergo mechanical thrombectomy for a stroke show a higher risk of mortality and a lower chance of a favorable neurological outcome at 90 days. However, the study found no significant difference in recanalization success or the risk of symptomatic intracranial hemorrhage between the two groups.

Are there different risks for patients with low heart function?

The data specifically showed that heart failure patients with reduced LVEF had higher mortality rates and worse functional outcomes compared to those without heart failure. These results suggest that heart function is a significant factor in recovery outcomes after a stroke.

Is the treatment for stroke less effective for heart patients?

The treatment success in terms of recanalization was not significantly different for patients with heart failure. While the initial procedure success was similar, the long-term outcomes, such as survival and functional recovery, were notably lower for those with heart failure.

Study Details

Study typeMeta analysis
Sample sizen = 3,587
EvidenceLevel 1
PublishedOct 2026
View Original Abstract ↓
BackgroundMechanical thrombectomy (MT) is an effective treatment for acute ischemic stroke, but its outcomes in patients with heart failure (HF) are uncertain. Some studies suggest worse outcomes in these patients, while others show no significant differences in mortality or functional recovery.MethodsWe systematically searched the MEDLINE, Embase, and Cochrane databases until August 2024. Studies were included if they compared patients with HF to those without. All statistical analyses were carried out using R, version 4.1.1. A subanalysis examined outcomes in HF patients with reduced left ventricular ejection fraction (LVEF).ResultsWe included 3587 patients, of which 1187 (33.1%) were in the HF group. We found a significantly higher mortality (RR 2.01; 95% CI: 1.33-3.03;  < 0.01) and lower risk of favorable neurologic outcome (RR 0.76; 95% CI: 0.67-0.86;  < 0.01) at 90 days on HF group, without a notable difference in the occurrence of symptomatic intracranial hemorrhage (sICH) (RR 1.57; 95% CI: 0.98-2.51;  = 0.06) or recanalization success (RR 1.02; 95% CI: 0.98-1.07;  = 0.28). HF patients with reduced LVEF also showed higher mortality (RR 1.91; 95% CI: 1.05-3.49;  = 0.03) and worse functional outcomes (RR 0.83; 95% CI: 0.72-0.95;  < 0.01) compared to those without HF.ConclusionsHF patients undergoing MT for ischemic stroke may have worse functional outcomes and higher mortality at 90 days compared to non-HF patients despite similar rates of sICH and recanalization success. Our findings suggest that patients with HF may have a worse prognosis compared to those without HF following MT for ischemic stroke.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.